Search results
European Medicines Agency pulls authorization for AstraZeneca's COVID shot, at company's request
WSLS Newschannel 10 Roanoke· 55 minutes agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine...
How mRNA vaccines could be personalized cancer cures
Axios· 23 hours agoWhy it matters: This personalized approach could make conditions like melanoma and bladder, kidney, pancreatic and breast cancers treatable, and even...
AstraZeneca withdraws Covid vaccine as demand dives
Alaska Superstation· 3 hours agoAnglo-Swedish drugmaker AstraZeneca on Wednesday said it was withdrawing Covid vaccine Vaxzevria, one of the first produced in the deadly pandemic,...
What's Going With BioNTech Stock On Monday?
Benzinga via Yahoo Finance· 2 days agoMonday, BioNTech SE (NASDAQ:BNTX) reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the...
BioNTech Slips To Loss In Q1 On Weak Revenues, Backs FY24 View; Stock Dips In Pre-market
RTT News· 2 days agoIn pre-market activity on the Nasdaq, BioNTech shares were trading at $88.05, down 5.04 percent. The year-over-year change was mainly due to lower commercial revenues from ...
BioNTech Slips To Loss In Q1
RTT News· 2 days agoImmunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Monday a net loss of 315.1 million euros or 1.31 euros per share for the first quarter, compared to net profit of 502.
Safe and Effective? The New York Times Revisits the COVID Jab. - The American Spectator | USA News...
American Spectator· 4 days agoIt has taken three years, but the New York Times has finally admitted that maybe, just maybe, there are some serious side effects to COVID vaccines. AstraZeneca, which has ...
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Benzinga via AOL· 7 days agoWednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 7 days agoPromisingly, Pfizer said in February its RSV vaccine, Abrysvo, proved 77.8% effective over two years...
16 out of 24 health care companies beat topline numbers this week- Earnings scorecard
Seeking Alpha· 4 days agoThis article provides an overview of the healthcare sector's recent quarterly earnings and highlights key companies like Pfizer, CVS Health, Moderna, Amgen,...